Furthermore, sensitivity to ATM-mediated growth inhibition in lung cancer cells correlates directly with expression of PKCι and Par6 but not to other proposed ATM targets such as thioredoxin reductases [19]. The gene discussed is PARD6A; the disease is lung cancer.